ScholarIQanswers from OpenAlex & ORCID
Richard A. Morgan
ResearcherPublications, citations & collaboration network
Richard A. Morgan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Richard A. Morgan have?
ScholarIQindexed works
Richard A. Morgan has 225 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Richard A. Morgan have?
ScholarIQcitation count
Richard A. Morgan has 16,590 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Richard A. Morgan?
ScholarIQh-index
Richard A. Morgan has an h-index of 51 in OpenAlex.
What is the i10-index of Richard A. Morgan?
ScholarIQi10-index
Richard A. Morgan has an i10-index of 87 in OpenAlex.
What is the ORCID of Richard A. Morgan?
ScholarIQorcid
The ORCID for Richard A. Morgan is on the source record.
What is the OpenAlex record for Richard A. Morgan?
ScholarIQopenalex
The OpenAlex for Richard A. Morgan is on the source record.
What are the most-cited papers on Richard A. Morgan?
ScholarIQmost cited works
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, James C. Yang, Richard M. Sherry, Mark E. Dudley, John R. Wunderlich, Azam Nahvi, Lee J. Helman, Crystal L. Mackall, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Catherine Lévy, Yong F. Li, Mona El‐Gamil, Susan Schwarz, Carolyn M. Laurençot, Steven A. Rosenberg
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James Chih‐Hsin Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Yong F. Li, Mona El‐Gamil, Steven A. Rosenberg
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
Stephanie L. Goff, Richard A. Morgan, James C. Yang, Richard M. Sherry, Paul F. Robbins, Nicholas P. Restifo, Steven A. Feldman, Yong‐Chen Lu, Lily Lu, Zhili Zheng, Liqiang Xi, Monica Epstein, Lori McIntyre, Parisa Malekzadeh, Mark Raffeld, Howard A. Fine, Steven A. Rosenberg